[ad_1]
BEIJING (AFP) – China's drug regulator said it has launched a nationwide inspection of vaccine production as a step-up to a case that has re-ignited public fears over the safety of the country's medicines.
State Drug Administration said in an announcement issued late on Wednesday (July 25) that it had dispatched inspection teams "to a full investigation of the whole process and whole chain of vaccine production of all vaccine producers."
China's latest product-safety scare emerged Changchun Changsheng Biotechnology has been produced and has been ordered to produce the rabies vaccine.
The case leap to the top of the national agenda
Police in the northeastern city of Changchun announced o n Tuesday that 15 people, including the company's chairman, had been arrested on "suspicion of criminal offenses."
The government has said the problematic rabies vaccine had not left Changsheng's factory standard vaccine for diphtheria, whooping cough and tetanus.
The depth of public outrage revealed on social media appeared to have caught off-guard ratings, and national leaders have scrambled in recent days to a thorough safety clean-up of the pharmaceutical
In a sign of the high-level unease, President Xi Jinping – we have a trip to Africa – weighing in the forefront of the vaccine company's actions "vile in nature and shocking", according to state media. 19659002] China is regularly hit by scandals involving sub-par or toxic food, drugs and other products, but it was canceled by the ruling Communist Party to address the problem
[ad_2]
Source link
